146 related articles for article (PubMed ID: 8076359)
1. Potentiation of ricin A immunotoxin by monoclonal antibody targeted monensin containing small unilamellar vesicles.
Singh M; Griffin T; Salimi A; Micetich RG; Atwal H
Cancer Lett; 1994 Aug; 84(1):15-21. PubMed ID: 8076359
[TBL] [Abstract][Full Text] [Related]
2. Monensin in lipid emulsion for the potentiation of ricin A chain immunotoxins.
Griffin T; Raso V
Cancer Res; 1991 Aug; 51(16):4316-22. PubMed ID: 1868454
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of antitumor immunotoxins by liposomal monensin.
Griffin T; Rybak ME; Recht L; Singh M; Salimi A; Raso V
J Natl Cancer Inst; 1993 Feb; 85(4):292-8. PubMed ID: 8426373
[TBL] [Abstract][Full Text] [Related]
4. Role of monensin PLGA polymer nanoparticles and liposomes as potentiator of ricin A immunotoxins in vitro.
Ferdous AJ; Stembridge NY; Singh M
J Control Release; 1998 Jan; 50(1-3):71-8. PubMed ID: 9685874
[TBL] [Abstract][Full Text] [Related]
5. Conjugation of anti-My9 antibody to stealth monensin liposomes and the effect of conjugated liposomes on the cytotoxicity of immunotoxin.
Sudhan Shaik M; Kanikkannan N; Singh M
J Control Release; 2001 Oct; 76(3):285-95. PubMed ID: 11578743
[TBL] [Abstract][Full Text] [Related]
6. In vivo potentiation of ricin toxicity by monensin delivered through liposomes.
Vasandani VM; Madan S; Ghosh PC
Biochim Biophys Acta; 1992 Jun; 1116(3):315-23. PubMed ID: 1377030
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of the specific cytotoxicity of a breast cancer-associated antigen immunotoxin by the carboxylic ionophore monensin.
Griffin TW; Pagnini PG; Houston LL
J Biol Response Mod; 1987 Oct; 6(5):537-45. PubMed ID: 3500277
[TBL] [Abstract][Full Text] [Related]
8. Long-circulating monensin nanoparticles for the potentiation of immunotoxin and anticancer drugs.
Shaik MS; Ikediobi O; Turnage VD; McSween J; Kanikkannan N; Singh M
J Pharm Pharmacol; 2001 May; 53(5):617-27. PubMed ID: 11370701
[TBL] [Abstract][Full Text] [Related]
9. Potent cytotoxicity of an antihuman transferrin receptor-ricin A-chain immunotoxin on human glioma cells in vitro.
Recht LD; Griffin TW; Raso V; Salimi AR
Cancer Res; 1990 Oct; 50(20):6696-700. PubMed ID: 2208135
[TBL] [Abstract][Full Text] [Related]
10. Stealth monensin immunoliposomes as potentiator of immunotoxins in vitro.
Singh M; Ferdous AJ; Kanikkannan N; Faulkner G
Eur J Pharm Biopharm; 2001 Jul; 52(1):13-20. PubMed ID: 11438419
[TBL] [Abstract][Full Text] [Related]
11. Recombinant ricin A chain conjugated to monoclonal antibodies: improved tumor cell inhibition in the presence of lysosomotropic compounds.
Ramakrishnan S; Bjorn MJ; Houston LL
Cancer Res; 1989 Feb; 49(3):613-7. PubMed ID: 2783383
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of ricin toxin A chain immunotoxin activity: synthesis, ionophoretic ability, and in vitro activity of monensin derivatives.
Dosio F; Franceschi A; Ceruti M; Brusa P; Cattel L; Colombatti M
Biochem Pharmacol; 1996 Jul; 52(1):157-66. PubMed ID: 8678901
[TBL] [Abstract][Full Text] [Related]
13. In vitro cytotoxicity of recombinant ricin A chain-antitransferrin receptor immunotoxin against human adenocarcinomas of the colon and pancreas.
Griffin TW; Pagnini PG; McGrath JJ; McCann JC; Houston LL
J Biol Response Mod; 1988 Dec; 7(6):559-67. PubMed ID: 3265147
[TBL] [Abstract][Full Text] [Related]
14. Blocking effect of human serum but not of cerebrospinal fluid on ricin A chain immunotoxin potentiation by monensin or carrier protein-monensin conjugates.
Candiani C; Franceschi A; Chignola R; Pasti M; Anselmi C; Benoni G; Tridente G; Colombatti M
Cancer Res; 1992 Feb; 52(3):623-30. PubMed ID: 1732050
[TBL] [Abstract][Full Text] [Related]
15. Effect of monensin liposomes on the cytotoxicity of anti-My9-bR immunotoxin.
Shaik MS; Jackson TL; Singh M
J Pharm Pharmacol; 2003 Jun; 55(6):819-25. PubMed ID: 12841943
[TBL] [Abstract][Full Text] [Related]
16. Folate receptor mediated targeted delivery of ricin entrapped into sterically stabilized liposomes to human epidermoid carcinoma (KB) cells: effect of monensin intercalated into folate-tagged liposomes.
Tyagi N; Ghosh PC
Eur J Pharm Sci; 2011 Jul; 43(4):343-53. PubMed ID: 21621613
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of a weakly active ricin A chain immunotoxin recognizing the neural cell adhesion molecule.
Derbyshire EJ; Stahel RA; Wawrzynczak EJ
Clin Exp Immunol; 1992 Sep; 89(3):336-40. PubMed ID: 1325302
[TBL] [Abstract][Full Text] [Related]
18. Potent cytotoxic action of the immunotoxin SWA11-ricin A chain against human small cell lung cancer cell lines.
Derbyshire EJ; Henry RV; Stahel RA; Wawrzynczak EJ
Br J Cancer; 1992 Sep; 66(3):444-51. PubMed ID: 1325825
[TBL] [Abstract][Full Text] [Related]
19. Monensin intercalation in liposomes: effect on cytotoxicities of ricin, Pseudomonas exotoxin A and diphtheria toxin in CHO cells.
Madan S; Ghosh PC
Biochim Biophys Acta; 1992 Sep; 1110(1):37-44. PubMed ID: 1390834
[TBL] [Abstract][Full Text] [Related]
20. An anti-mucin immunotoxin BrE-3-ricin A-chain is potently and selectively toxic to human small-cell lung cancer.
Derbyshire EJ; Wawrzynczak EJ
Int J Cancer; 1992 Oct; 52(4):624-30. PubMed ID: 1328073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
